BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32721511)

  • 1. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
    Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
    Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
    Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
    Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
    Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
    Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the c-kit gene in testicular germ cell tumors.
    Sakuma Y; Sakurai S; Oguni S; Hironaka M; Saito K
    Cancer Sci; 2003 Jun; 94(6):486-91. PubMed ID: 12824871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of BRAF and RAS are rare events in germ cell tumours.
    Sommerer F; Hengge UR; Markwarth A; Vomschloss S; Stolzenburg JU; Wittekind C; Tannapfel A
    Int J Cancer; 2005 Jan; 113(2):329-35. PubMed ID: 15386408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.
    Willmore-Payne C; Holden JA; Chadwick BE; Layfield LJ
    Mod Pathol; 2006 Sep; 19(9):1164-9. PubMed ID: 16741525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature.
    Goddard NC; McIntyre A; Summersgill B; Gilbert D; Kitazawa S; Shipley J
    Int J Androl; 2007 Aug; 30(4):337-48; discussion 349. PubMed ID: 17573850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.
    Chuang J; Wang C; Guo Y; Valenzuela V; Wu J; Fakih M
    Clin Colorectal Cancer; 2021 Mar; 20(1):72-78. PubMed ID: 33436306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary mediastinal seminomas: evidence of single and multiple KIT mutations.
    Przygodzki RM; Hubbs AE; Zhao FQ; O'Leary TJ
    Lab Invest; 2002 Oct; 82(10):1369-75. PubMed ID: 12379771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.
    Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB
    Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
    Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
    Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT mutations are common in testicular seminomas.
    Kemmer K; Corless CL; Fletcher JA; McGreevey L; Haley A; Griffith D; Cummings OW; Wait C; Town A; Heinrich MC
    Am J Pathol; 2004 Jan; 164(1):305-13. PubMed ID: 14695343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors.
    McIntyre A; Summersgill B; Spendlove HE; Huddart R; Houlston R; Shipley J
    Neoplasia; 2005 Dec; 7(12):1047-52. PubMed ID: 16354586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [KIT receptor in testicular seminoma].
    Paule B
    Prog Urol; 2005 Feb; 15(1):96-9; discussion 99. PubMed ID: 15822404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature.
    Coffey J; Linger R; Pugh J; Dudakia D; Sokal M; Easton DF; Timothy Bishop D; Stratton M; Huddart R; Rapley EA
    Genes Chromosomes Cancer; 2008 Jan; 47(1):34-42. PubMed ID: 17943970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
    Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
    Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-RAS and N-RAS mutations in testicular germ cell tumors.
    Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
    Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies.
    Kato S; Okamura R; Sicklick JK; Daniels GA; Hong DS; Goodman A; Weihe E; Lee S; Khalid N; Collier R; Mareboina M; Riviere P; Whitchurch TJ; Fanta PT; Lippman SM; Kurzrock R
    Int J Cancer; 2020 Jun; 146(12):3450-3460. PubMed ID: 31782524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating c-kit gene mutations in human germ cell tumors.
    Tian Q; Frierson HF; Krystal GW; Moskaluk CA
    Am J Pathol; 1999 Jun; 154(6):1643-7. PubMed ID: 10362788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.